Introduction
============

Melanins are dark, hydrophobic, negatively charged pigments that are widespread in nature ([@B26]). The structure of melanins remain unidentified, so they are defined as pigments that are complex polymers with a high molecular mass, amorphous nature, acid resistance, and with a stable free radical signal ([@B51]; [@B20]; [@B44]). There are several types of melanins: eumelanins, pheomelanins, alomelanins, and piomelanins ([@B6]; [@B44]; [@B31]). Some fungal melanins derive from the precursor molecule 1,8-dihydroxynaphthalene (DHN), such as those from *Wangiella dermatitidis* and *Alternaria alternata*, and are produced from endogenous substrates. Alternatetively, some fungi produce melanin from [L]{.smallcaps}-3,4 dihydroxyphenylalanine ([L]{.smallcaps}-DOPA; [@B10]).

Melanins contribute to the virulence of pathogens and increase resistance to environmental damage as well ([@B36]). In *Cryptococcus neoformans*, genes involved in melanization contribute to host death and dissemination from lungs ([@B38]; [@B28]). Melanization in *C. neoformans* is catalyzed by laccase, a cell wall associated diphenoloxidase that catalyzes the oxidation of diphenolic compounds to their respective quinones ([@B8]). However, *C. neoformans* cannot use tyrosine as a substrate to produce melanin ([@B29]). Two laccase encoding genes, *LAC1* and *LAC2*, have been identified in *C. neoformans*, with *LAC1* being the main producer of melanin ([@B32]). In addition, other genes including *VPH1, CCC2, ATX1, CHS3, MBF1*, and *XRN1* are also required for melanization, although in most cases their mode of action is not well characterized ([@B14]; [@B55]; [@B45]; [@B52]).

We have been recently interested in the role of cell cycle elements in the regulation of the expression of cryptococcal virulence factors, with special emphasis on the capsule. During the course of the characterization of *cln1*, a cyclin mutant of *C. neoformans* ([@B16]) we found out that it was unable to melanize. Cln1 is a G1 cyclin in *C. neoformans*. While it is not essential for cell cycle progression, it is responsible for a delay in the transition between G1 and S phases ([@B16]). Little is known about cell cycle progression in *C. neoformans*, but during exponential phase, budding and DNA synthesis occur simultaneously ([@B5]). However, at the end of exponential phase, budding is delayed and cells are arrested at G1 or G2 phases ([@B39]; [@B42]). We observed that capsule enlargement is coordinated with cell cycle progression. Therefore, and given that *cln1* was unable to melanize, we decided to study the relationship between this particular cyclin of *C. neoformans* and the ability of the yeast to produce melanin. Our results demonstrate that the production of melanin seems to be regulated through a complex pathway in which cell wall stability is essential. In addition, drugs that cause cell cycle arrest in G1/S phase results in defects in melanization.

Materials and Methods {#s1}
=====================

Strains and Culture Conditions
------------------------------

*Cryptococcus neoformans* var. *grubii* H99 strain ([@B30]) and the mutant CNAG_06092 (*cln1*) obtained from a collection of mutants deposited at the ATCC by Dr. Madhani ([@B22]) were used in this study. In addition, the reconstituted strain, *cln1::CLN1* was generated by biolistic transformation as described in ([@B16]).

The strains were routinely grown in liquid Sabouraud medium (Oxoid LTD, UK) at 30°C or 37°C with moderate shaking (150 rpm). To induce melanization, strains were grown protected from light in chemically defined minimal medium (15 mM dextrose, 10 mM MgSO~4~, 29.4 mM KHPO~4~, 13 mM glycine, and 3 μM thiamine, pH 5.5) with 1 mM [L]{.smallcaps}-DOPA (Sigma--Aldrich, St. Louis, MO, USA) and incubated at 30°C with shaking. In some cases, the same medium without [L]{.smallcaps}-DOPA was used as a control.

For solid media, 1.5% agar was added to the medium. Yeast suspensions were prepared at 2 × 10^7^/mL in PBS. Serial 1:10 dilutions were performed and 5 μL from each dilution were spotted. Plates were incubated at 30 and 37°C and pictures were taken daily. In some cases, 1M Sorbitol or Congo Red (0.05; 5 and 10 mg/mL) were added to Sabouraud agar plates.

Phylogenetic Tree
-----------------

We performed evolutionary studies of the Cln1 protein sequence using PhylomeDB (<http://phylomedb.org>; [@B17], [@B18]) by Dr. Gabaldón's lab (Comparative Genomics Group at Centre for Genomic Regulation, Barcelona, Spain). PhylomeDB is an algorithm that allows the visualization of the evolution of a specific gene by comparison of multiple genomes. After introduction of the protein sequence, the software performs multiple alignments and creates a tree where the evolution of a specific protein (duplication and speciation events) can be visualized and paralogs and orthologs identified.

Wheat Germ Agglutinin Staining
------------------------------

The presence of chitin-like structures, WGA staining was ascertained as described in ([@B33]). Briefly, *C. neoformans* cells with enlarged capsule (incubated in 10% Sabouraud in 50 mM MOPS buffer pH 7.3 overnight at 30°C; [@B53]) were washed in PBS and suspended in 4% *p*-formaldehyde for 30 min at room temperature. The fixed cells were washed and incubated in 100 μL of PBS containing 5 μg/mL of WGA conjugated to Alexa-594 (Molecular Probes, Invitrogen) for 1 h at 37°C. Next, cells were again washed and suspended in 100 μL of PBS. Cell suspensions were mounted over glass slides and photographed with a SP5 confocal microscope (Leica Microsystems).

Melanin Production
------------------

Melanin production was assessed on both liquid and solid chemically defined minimal medium (see above) supplemented with [L]{.smallcaps}-DOPA. After 24--48 h, melanization was assessed by acquisition of a dark color of the cultures, compared to parallel cultures without [L]{.smallcaps}-DOPA. For melanin production on solid medium, yeast suspensions were prepared at 2 × 10^7^/mL in PBS. Serial 1:10 dilutions were performed and 5 μL from each one were spotted on [L]{.smallcaps}-DOPA plates and on Sabouraud dextrose agar. Plates and cultures were incubated at 30 and 37°C protected from light. Pictures of either the plates or liquid cultures were taken daily.

Laccase Activity Assay
----------------------

*Cryptococcus neoformans* strains were incubated in 15 mL of chemically defined minimal medium with [L]{.smallcaps}-DOPA overnight at 30°C with shaking (150 rpm) and protected from light. Laccase activity was assessed as described in ([@B4]) with some modifications. Pelleted cells were suspended in 2 mL of PBS and divided in two equal fractions; one was used as a negative control by inactivating the laccase activity with 5% β-mercaptoethanol for 2 h at 37°C. Then, both aliquots were disrupted using a Fast Prep homogenizer (MP Biomedicals) 0.5 grams of 425--600 μm Ø glass beads (Sigma--Aldrich, St. Louis, MO, USA). A minimum of six cycles of 45 s were performed (with intervals of 4 min in ice). The mixture was centrifuged at 13,800 *g* for 10 min at 4°C. Supernatants were conserved at 4°C until enzymatic determination was performed. To quantify the laccase activity, 100 μL of every sample were placed in a 96 well-plate (Costar, NY, USA), and 7 μl of a 20 mM [L]{.smallcaps}-DOPA solution were added to each well. The microplate was incubated at 25°C with moderate shaking in an iEMS Spectrophotometer (Thermofisher) for 18 h. Optical density at 450 nm was measured every 15 min. Protein concentration of the extracts was determined with the Bradford method using the Quick Start Bradford Protein Assay (BioRad, CA, USA). Specific activity was expressed as mUAbs/min/μg protein.

Quantification of the Expression of the *LAC1* Gene by Real-Time PCR
--------------------------------------------------------------------

Yeast cells were grown for 3 days in minimal medium at 30°C with shaking (150 rpm) as described above. RNA extraction was performed using Trizol reagent protocol (Ambion RNA by life technologies) with some modifications. The cells were disrupted with glass beads using a FastPrep-24 (MP^TM^) for 5 min, alternating 20 s shaking with 1 min on ice. The RNAs were quantified and qualified using the Nanodrop 8000 Spectrophotometer (Thermo scientific). cDNAs were generated using the iScrip^TM^ cDNA synthesis Kit (Bio-Rad) following the manufacturer's recommendations. The RT-PCR was performed using SsoAdvanced^TM^ Universal SYBR^R^ Green Supermix (Bio-Rad) using the *LAC1* specific primers (LAC1F AGAAGGGAAGGAAGGTGATG and LAC1R1 TATACCTCACAACCGCCAAT described in ([@B1]) in a total volume of 20 μl, in a Light Cycler^R^ 480 ([@B46]). As control, 18s specific primers were used (18sF CCGTTGCTAGAGGTGAAATTCTTAG and 18sR ATCTAATCGTTTTTGATCCCCTAAC). The RT-PCR conditions were 95°C for 10 min and 40 cycles of amplification (95°C for 15 s, 58°C for 1 min). Differences in gene expression were calculated using the 2^-ΔΔCt^ method.

Susceptibility to Oxidative Stress
----------------------------------

*Cryptococcus neoformans* strains were incubated in [L]{.smallcaps}-DOPA liquid medium for 48 h at 30°C with shaking (150 rpm). Suspensions were prepared at 2 × 10^3^ cells/mL in PBS. Hydrogen peroxide (Fluka, St. Louis, MO, USA) was added at different final concentrations (0.5, 1, and 2 mM) and cells were incubated at 30°C for 1 h. Samples without hydrogen peroxide were incubated in parallel as controls. Each sample was carried out in triplicate. Then, 50 and 100 μL were plated on Sabouraud agar plates and incubated at 30°C for 2 days. The number of colony forming units (CFU) was enumerated, and viability was calculated as the percentage of colonies obtained in the treated samples compared with the untreated controls.

Melanin Production in the Presence of Cell Cycle Inhibitors
-----------------------------------------------------------

*Cryptococcus neoformans* strain H99 cells were grown in 5 mL of Sabouraud at 30°C with agitation. Cells were washed and transferred to [L]{.smallcaps}-DOPA liquid medium containing different rapamycin concentrations (0.5 and 1 μg/mL, Sigma--Aldrich, St. Louis, MO, USA), which induces G1 arrest. The same amount of DMSO (Sigma--Aldrich, St. Louis, MO, USA) was added to the control cultures (without the drug) since rapamycin is diluted in this solvent. Cells were grown overnight at 30°C and pictures were taken daily to asses melanization.

To assess cell viability after treatment with the different concentrations of rapamycin cells were stained with propidium iodide at a final concentration of 5 μg/ml and quantified by flow cytometry using a FacsCalibur flow cytometer (BD, Biosciences, Worburn, MA, USA). Data were processed using CellQuest (BD, Biosciences) and FlowJo (Tree Star Inc, Ashland, OR, USA) softwares.

Growth Curves in [L]{.smallcaps}-DOPA Liquid Medium in the Presence of Cell Cycle Inhibitors
--------------------------------------------------------------------------------------------

Suspensions of *C. neoformans* strain H99 at 5 × 10^5^/mL were prepared in chemically defined minimal medium with 1 mM [L]{.smallcaps}-DOPA containing different concentrations of rapamycin (0, 0.5, or 1 μg/mL). Control suspensions of *C. neoformans* cells in chemically defined medium with DMSO were carried out in parallel in each case. Cells were grown for 48 h at 30°C and optical density at 540 nm was assessed every hour using an iEMS Spectophotomer (Thermofisher). Graphs were plotted using Graph Pad Prism 5.

Statistical Analysis
--------------------

Scatter plot graphs of cell sizes were done using Graph Pad Prism 5 (La Jolla, CA, USA), and statistical differences were assessed with *t*-test. A *p*-value \<0.05 was considered significant.

Results
=======

Phylogenetic Analysis of Cln1
-----------------------------

Previous work from our laboratory had focus on the role of Cln1 on capsule production ([@B16]). During the characterization of the role of this protein on *C. neoformans* capsule formation, we found that the corresponding mutant strain presented some abnormal phenotypes that were not expected to be related with cell cycle regulation, such as a defect in melanization. In consequence, we decided to further characterize phenotypically this mutant. First, we performed a blast comparison using PhylomeDB, an algorithm that allows the generation of phylogenetic evolutionary trees and the identification of gene paralogs and orthologs. The results showed that although Cln1 had evolutionary similarities with cyclins from other organisms, in *C. neoformans*, this cyclin had evolved specifically with proteins present only in other basidiomycetes after two duplication events from a common ancestor (**Figure [1](#F1){ref-type="fig"}**). Therefore, it is possible that this protein has new roles in *C. neoformans* development and/or pathogenesis independently of cell cycle functions.

![**Phylogenetic tree of G1/S cyclin (Cln1).** A phylogenetic tree analysis of *Cryptococcus neoformans* Cln1 protein sequence was performed using PhylomeDB as described in Materials and Methods. The sequence of *Candida albicans* Ccn1 was used as root. The location of the *C. neoformans* Cln1 sequence is highlighted with a black arrow. Red dots indicate duplication events, and in consequence, appearance of paralogs, and blue dots denote speciation events and appearance of orthologs.](fmicb-06-00798-g001){#F1}

Growth and Morphological Characteristics of *cln1* Mutant
---------------------------------------------------------

We investigated the growth rate of *cln1* at different temperatures. The mutant *cln1* showed growth defects at 37°C in Sabouraud (**Figure [2](#F2){ref-type="fig"}**). However, this defect was partially restored when 1 M Sorbitol was added (**Figure [2](#F2){ref-type="fig"}**). Interestingly, sorbitol did not restore other morphological defects described for this mutant, such as an engrossment of the bud neck or enlarged cell size (data not shown). This result suggested that *cln1* had cell wall defects. Therefore, we investigated if *cln1* was more susceptible to agents that affect the stability of the cell wall, such as Congo Red (CR). As shown in **Figure [3](#F3){ref-type="fig"}**, CR inhibited *cln1* growth in a dose dependent manner, which was linked to possible cell wall alterations. We tested other cell wall disturbing compounds, such as tunicamycin, or osmotic stress (NaCl), but we did not find any difference in the growth between any of the strains.

![**Growth of *cln1* mutant on solid medium.** Panels show fungal growth on Sabouraud agar plates, Sabouraud agar plates supplemented with 1 M Sorbitol, at 30°C (upper panels) and at 37°C (lower panels). Upper numbers indicate the number of cells placed in each spot. Pictures were taken after 48 h.](fmicb-06-00798-g002){#F2}

![**Cell wall stability assay.** Growth of wt, *cln1* and the reconstituted strains on Sabouraud agar plates with different Congo Red (CR) concentrations. Plates were incubated at 30°C and pictures were taken after 48 h.](fmicb-06-00798-g003){#F3}

Chitin-like molecules in fungi are polymerized by chitin synthases, which use cytoplasmic pools of UDP-GlcNAc (*N*-acetylglucosamine) to form β-1,4-linked oligosaccharides and large polymers. In *C. neoformans*, the final cellular site of chitin accumulation is the cell wall, although some protuberances of this structure have been also found in the capsule ([@B33]). The chitin-like structures in the capsule can be visualized by the binding of fluorescent wheat germ agglutinin, which binds to sialic acids and β-1,4-*N*-acetylglucosamine (GlcNAc) oligomers ([@B33]). We used WGA to ascertain whether these structures were also present in the *cln1* mutant. Cells from the wild type and *cln1::CLN1* strains bound WGA at the neck between the mother cell and the bud. In contrast, in cells from the *cln1* strain, these structures were delocalized and were found all over the cell giving also a more intense fluorescent signal (**Figure [4](#F4){ref-type="fig"}**).

![**Binding of wheat germ agglutinin to *C. neoformans* strains.** Panels show representative cells of each strain grown in capsule inducing medium at 30°C for 24 h stained with WGA as described in Section "Materials and Methods."](fmicb-06-00798-g004){#F4}

Melanin Production and Laccase Activity
---------------------------------------

During the phenotypic characterization of *cln1*, we observed that Cln1 was required for the accumulation of melanin (**Figure [5A](#F5){ref-type="fig"}**). Wild type and *cln1::CLN1* strains produced melanin after 3--4 days of incubation at 30°C on [L]{.smallcaps}-DOPA agar plates (**Figure [5A](#F5){ref-type="fig"}**) while *cln1* mutant was unable to accumulate melanin. In liquid medium, we found that melanization of the wt and *cln1::CLN1* strains was visible after 24 h of incubation with [L]{.smallcaps}-DOPA, while the *cln1* mutant did not accumulate melanin.

![**Melanin production and laccase activity. (A)** Growth of *C. neoformans* strains on [L]{.smallcaps}-3,4 dihydroxyphenylalanine ([L]{.smallcaps}-DOPA) agar plates at 30°C. **(B)** Laccase activity of *C. neoformans* strains. A *p*-value \<0.05 is indicated with an asterisk. **(C)** *LAC1* gene expression. Cells from WT, *cln1* and *CLN::CLN1* strains were grown in minimal media for 3 days at 30°C and RNA samples were isolated. cDNAs were obtained and relative expression of the *LAC1* gene was measured by real time PCR.](fmicb-06-00798-g005){#F5}

To get insights about this phenotype, we measured the laccase activity in the wild type and mutant strains ([@B54]). In agreement with the visual observation showing absent melanization, the *cln1* mutant had no laccase activity in the conditions tested. This defect was recovered in the reconstituted strain (**Figure [5B](#F5){ref-type="fig"}**).

We then investigated if the defect in laccase activity was due to a defect at the transcriptional level. We measured the relative levels of the mRNA of the *LAC1* gene by real-time PCR. For this purpose, total RNA was isolated from cells grown in minimal medium and cDNA was obtained using standard protocols. We then used this cDNA as template to quantify the levels of the *LAC1* mRNA. The expression of the *LAC1* gene in the *cln1* mutant was significantly lower than in the WT strain, and this defect was partially complemented in the reconstituted strain (**Figure [5C](#F5){ref-type="fig"}**), indicating that absence of melanization was mainly due to a defect in the transcription of the *LAC1* gene.

Melanin Protects *C. neoformans* from Oxidative Damage
------------------------------------------------------

Laccase and melanin confer resistance to oxidative damage ([@B47]), and consequently we tested the susceptibility of Cln1 sufficient and deficient strains to H~2~O~2~. Cells from WT and *cln1::CLN1* grown for 48 h in [L]{.smallcaps}-DOPA liquid medium showed resistance to oxidative stress at all concentrations tested (0.5, 1, and 2 mM, **Figure [6](#F6){ref-type="fig"}**). In contrast, *cln1* cells grown in the same conditions showed a five-fold reduction in survival when exposed to H~2~O~2~, even when using low H~2~O~2~ concentrations such as 0.5 mM (**Figure [6](#F6){ref-type="fig"}**). In contrast, *cln1* and WT cells grown in Sabouraud liquid medium showed no statistical significant differences in survival when incubated with different concentrations of H~2~O~2~ (data not shown).

![**Susceptibility to oxidative stress.** Bars show different susceptibility of *C. neoformans* strains grown in [L]{.smallcaps}--DOPA liquid medium and incubated in the presence of different H~2~O~2~ concentrations for 1 h.](fmicb-06-00798-g006){#F6}

Melanin Production in the Presence of Cell Cycle Inhibitors
-----------------------------------------------------------

The lack of melanization in *cln1* suggested a link between cell cycle elements and the capability to produce and/or accumulate melanin. Therefore we examined if melanin production was affected by drugs that cause cell cycle arrest. First, we tested melanization in [L]{.smallcaps}-DOPA liquid cultures containing different concentrations of rapamycin (0.5 and 1 μg/mL), which is an inhibitor of the TOR signaling pathway and causes G1 arrest. As shown in **Figure [7](#F7){ref-type="fig"}**, rapamycin inhibited melanin production by *C. neoformans* in [L]{.smallcaps}-DOPA liquid cultures (**Figure [7A](#F7){ref-type="fig"}**). To assess if lack of melanization was due to an inhibitory effect of rapamycin on growth rate, we studied growth in [L]{.smallcaps}-DOPA liquid medium with different concentrations of rapamycin and observed that this drug had no inhibitory effect on the growth rate of *C. neoformans* in [L]{.smallcaps}-DOPA liquid medium (**Figure [7B](#F7){ref-type="fig"}**).

![**Effect of rapamycin on melanization and growth of *C. neoformans*. (A)** Panels show cultures of *C. neoformans* in [L]{.smallcaps}-DOPA liquid medium containing different rapamycin concentrations at 0 and 48 h. Cultures with DMSO were carried out in parallel since rapamycin was dissolved in DMSO. **(B)** Growth of *C. neoformans* in [L]{.smallcaps}-DOPA medium containing different rapamycin concentrations. Optical density (OD) was measured at 540 nm every hour for 48 h. Black line, growth in control medium (minimal medium + DMSO); red line, rapamycin 0.5 μg/mL; green line, rapamycin 1 μg/mL.](fmicb-06-00798-g007){#F7}

Discussion
==========

During the phenotypic characterization of the *cln1* mutant, we found that it was unable to synthesize melanin in the presence of substrates such as [L]{.smallcaps}-DOPA. The production of melanin is known to confer protection against different stress conditions ([@B21]; [@B13]; [@B48],[@B49]; [@B37]). Some factors that regulate melanization have already been described ([@B2], [@B3]; [@B9]; [@B27]; [@B41]; [@B40]; [@B23]). In *C. neoformans* this process only takes place in the presence of specific substrates, mainly diphenolic compounds ([@B7], [@B8]). Melanization depends on the expression of a gene that encodes a diphenol oxidase, called laccase, and the expression of this gene is repressed by glucose ([@B29]). Our initial finding suggested that melanization is in fact under the regulation of a more complex circuit, and for that reason, we decided to characterize this phenotype in detail.

Consistent with its role in cell cycle regulation, the cyclin mutant displayed growth defects, especially at 37°C. This might be explained by the fact that some genes that are expressed at the G1/S phase boundary are involved in cell wall biosynthesis ([@B19]). This idea is supported by the restoration of the growth defect phenotype after the addition of osmotic stabilizers (sorbitol) to the media and the higher susceptibility to agents that alter the stability of the cell wall such as CR. We tested if the *cln1* mutant had any defect in the activation of MAPK that are involved in the response to cell wall alterations (such as Mkc1 and Cek1; [@B25], [@B24]; [@B12]; [@B35]), but our preliminary data showed no difference in the activation of these kinases between any of the strains tested in this work (data not shown).

Laccase in *C. neoformans* is synthesized in the cytoplasm ([@B20]; [@B15]; [@B11]) and then it is believed to be transported in vesicles to the cell wall, where it is finally tightly linked through disulfide or thioester bonds. ([@B54]; [@B50]; [@B34]). The mutant *cln1* presents cell wall defects and miss localization of chitin like structures as evidenced by the delocalized binding of WGA. Therefore, we believe that laccase is not correctly linked to cell wall and thus, the *cln1* mutant strain is unable to produce melanin. This phenotype was also confirmed independently by testing the susceptibility of *cln1* to stress factors, such as H~2~O~2~, and the effect of cell cycle inhibitors on melanization. Our results are in agreement with previous findings that described that melanization depends on proteins involved in cell wall structure, such as Chs3 ([@B45]).

Curiously, we observed that *cln1* could grow normally at 37°C in minimal medium. Growth curves performed with *C. neoformans* WT strain in the presence of cell cycle inhibitors in minimal medium revealed that rapamycin had no effect on growth rate. These results suggest that neither rapamycin, nor Cln1 regulate growth rate in minimal medium, although they are necessary to melanize. Cln1 has been involved in the regulation of cell cycle in *C. neoformans* ([@B42], [@B43]; [@B16]). However, our findings suggest that in certain conditions, cell cycle progression does not depend on Cln1 nor Tor proteins, and these proteins seem to have other functions in other metabolic processes, such as melanin production, independently of cell cycle regulation.

Finally, our results show a plausible link between cell cycle and melanin production. The phylogenetic analysis showed that Cln1 had evolved differently compared to cyclins of other microorganisms, and that this evolutionary pattern is only present in basidiomycetes. This result suggests that Cln1 of *C. neoformans* has acquired specific functions that are not present in other microorganisms, and thus, it could regulate processes, such as melanin production, characteristic of *C. neoformans*. Cln1 modulates G1/S transition in *C. neoformans* and its absence leads to defects on virulence determinants, such as melanin production. This study offers new directions in cryptococcal virulence research and the possibility of new drug targets involved in cell cycle progression.
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